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Summary
Introduction:  Acinic  cell  carcinoma  is  a  rare  form  (2—4%)  of  parotid  tumor.  It  is,  however,  the
most frequent  form  of  bilateral  parotid  tumor  and  the  second  most  frequent  form  in  children.
Case report:  A  22-year-old  man  had  several  years’  history  of  left  parotid  tumor,  discovered  toAcinic  cell
carcinoma;
Parotid  imaging
be acinic  cell  carcinoma.  MRI  found  a  synchronous  contralateral  tumor  of  the  same  histologic
nature.
Discussion/Conclusion:  This  case  highlights  the  need  for  rigorous  examination  of  the  contralat-
eral parotid  in  case  of  parotid  tumor  and  especially  of  acinic  cell  carcinoma.
© 2012  Elsevier  Masson  SAS.  All  rights  reserved.
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cinic  cell  carcinoma  is  rare,  at  2—4%  of  parotid  tumors  and
0—18%  of  parotid  cancers  [1].  It  is  bilateral  in  3—5%  of  cases
2],  although  less  than  20  cases  have  been  reported  [3].  Inci-
ence  is  predominantly  in  the  5th  decade,  but  it  may  also
ccur  in  children,  in  whom  it  is  the  second  most  frequent
orm  of  malignant  tumor  [1].We  present  a  case  of  bilateral  synchronous  parotid  acinic
ell  carcinoma  in  a  22-year-old  man.
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 22-year-old  man,  with  no  particular  history  except  obesity
BMI  =  41  kg/m2),  consulted  for  left  parotid  tumor.  He  had
een  aware  of  this  mass  for  more  than  10  years;  it  had  been
ncreasing  in  volume  for  some  months  but  without  pain.
Clinical  examination  found  a  large  4-cm  left  parotid
ass,  ﬁrm,  mobile  and  pain-free  on  palpation,  without  para-
haryngeal  extension.  There  was  no  facial  palsy,  palpable
denopathy,  cutaneous  inﬁltration  or  abnormality  in  the  ori-
ce  of  Stenon’s  canal.
Fine-needle  aspiration  cytology  was  performed  duringhe  consultation  and  parotid  MRI  was  performed  with
onventional  (T1-weighted,  T2-weighted  and  gadolinium-
nhanced  T1)  plus  dynamic  perfusion  and  diffusion-weighted
equences.
served.
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Figure  1  A.  Left  parotid  tumor  (*):  T2-weighted  MRI.  Axial  slice.  B.  Right  parotid  tumor  (*):  T2-weighted  MRI.  Axial  slice.  C.  Left
 MRI.  Coronal  slice.  D.  Time-intensity  curves  of  the  left  (solid  line)
RI.
Figure  2  Left  parotid  tumor:  ﬁne  needle  aspiration  cytology.
C
c
band right  parotid  tumors  (*):  T1-weighted  gadolinium-enhanced
and right  (dotted  line)  tumors;  dynamic  gadolinium-enhanced  M
MRI  found  a  35-mm  left  parotid  T2N0M0  tumor,  and  also
a  smaller,  deep  14-mm  contralateral  parotid  T1N0M0  tumor,
not  clinically  palpable.  Both  tumors  presented  the  same
aspects:  polylobated,  regularly  contoured,  in  T1  hyposig-
nal  and  T2  hypersignal  with  homogeneous  enhancement,
suggestive  of  benign  lesions,  on  conventional  sequences
(Figs.  1A—C); in  both  tumors,  however,  the  enhancement
proﬁle  on  dynamic  perfusion  corresponded  to  a  B-type
(washout)  curve  with  a  relatively  elevated  apparent  diffu-
sion  coefﬁcient,  suggestive  of  malignancy  (Fig.  1D).
Fine-needle  aspiration  cytology  of  the  left  parotid  lesion
found  cells  with  abundant  ﬁnely  vacuolated  cytoplasm,  sug-
gestive  of  acinic  cell  carcinoma  (Fig.  2).  The  right  parotid
tumor  was  not  accessible  even  to  US-guided  cytology,  due
to  its  depth  and  small  size.
In  the  absence  of  proof  of  malignancy  in  the  right  parotid
lesion,  it  was  decided  to  treat  the  two  tumors  in  two
steps.  Left  parotidectomy  was  quickly  performed;  extem-
poraneous  anatomopathology  conﬁrmed  diagnosis  and  led
to  total  parotidectomy  with  cervical  lymph—node  resection.
Deﬁnitive  analysis  conﬁrmed  the  histologic  diagnosis  of
low-grade  acinic  cell  carcinoma.  Resection  was  considered
complete,  with  no  lymph—node  metastasis  on  specimen
analysis  (Fig.  3A).
Adjuvant  60  Gy  radiation  therapy  was  performed  6  weeks
postoperatively.
s
E
nlusters  of  large  tumor  cells  (→)  with  large  micro-vacuolated
ytoplasm  and  round  nucleus,  not  atypical,  in  contact  with
lood  cells  (*).  Methylene  blue,  ×  10.Right  parotidectomy  was  performed  in  a  second  step,
ome  months  after  the  end  of  the  left  parotid  treatment.
xtemporaneous  examination  diagnosed  acinic  cell  carci-
oma,  conﬁrmed  on  deﬁnitive  analysis  (Fig.  3B).  Resection
24  
Figure  3  A.  Left  parotid  tumor:  deﬁnitive  histological  analy-
sis. Tumor  invasion  with  solid  acinic  tumor  cell  areas,  and  large
micro-vacuolated  basophilic  granular  cytoplasm  (→),  within
ﬁbrous  capsule  (*).  HES,  ×  10.  B.  Right  parotid  tumor:  deﬁni-
tive histological  analysis.  Same  aspect  as  contralateral  tumor:
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Rlusters  of  acinic  tumor  cells  (→)  within  ﬁbrous  capsule  (*).
ES, ×  10.
as  juxta-lesional,  in  contact  with  the  facial  nerve.  There
ere  no  lymph—node  metastases  on  specimen  analysis.
djuvant  60  Gy  radiation  therapy  was  again  performed
 weeks  postoperatively.
In  both  operations,  the  facial  nerve  was  spared;  there
ere  no  postoperative  complications.
iscussion
ilateral  primary  malignant  parotid  gland  tumors  are  a rare
ccurrence;  synchronicity  is  exceptional.  Acinic  cell  carci-
oma  is  the  most  frequent  histologic  form  [1].  In  children,
%  of  acinic  cell  carcinomas  are  bilateral.  Very  few  such
ases  have  been  reported  in  the  literature  [3].  Two  cases  of  a
amilial  form  were  described,  with  a  cytogenetic  hypothesis
ased  on  ﬁndings  of  chromosomal  mutations  (in  regions  4p,
q,  6p,  17p  [3,4]  or  6q,  Y-chromosome  deletion  [5])  probably
nvolving  tumor  suppression  genes.  This  malignant  tumor  is
sually  low-grade  and  slow-growth,  and  was  long  consideredN.  Durand  et  al.
enign  [6];  it  is  usually  revealed  by  a  parotid  swelling,  which
ay  be  painful  or  sensitive  (in  10  to  50%  of  cases  [2,4]), or
ssociated  with  facial  palsy  (in  3  to  7%  of  cases  [4,7]). There
re  more  aggressive  dedifferentiated  forms  [6]  and  progno-
is  is  dependent  on  histologic  type,  which  in  turn  correlates
ith  risk  of  metastasis  [7].
Diagnosis  is  based  on  anatomopathologic  examination  of
he  parotidectomy  specimen,  as  acinic  cell  carcinoma  is
ytologically  similar  to  benign  forms,  causing  frequent  false
egative  on  ﬁne-needle  aspiration,  which  seemingly  ﬁnds
 normal  parotid  or  a  benign  tumor  [4].  Likewise,  there  is
o  speciﬁc  MRI  signal  distinguishing  it  from  a  benign  tumor
n  conventional  sequences  [4].  On  the  other  hand,  as  in
he  present  case,  dynamic  perfusion  sequences  associated
o  diffusion-weighted  sequences  are  able  to  suggest  malig-
ancy  [8].
Treatment  is  based  on  surgical  resection  by  total
arotidectomy  [4,7,9]  associated  to  cervical  lymph—node
esection  (10%  cervical  lymph—node  metastasis  [2]).  Radi-
tion  therapy  should  be  considered,  especially  in  case  of
actors  of  poor  prognosis  (positive  resection  margins,  stage
3  or  T4  tumor,  high  histologic  grade  tumor,  vascular  or  per-
neural  invasion)  [4,9]. Management  of  bilateral  forms  poses
 dosimetric  challenge,  which  may  be  met  by  intensity-
odulated  radiation  therapy  (IMRT)  [10].
Prognosis  is  good  (65  to  90%  5-year  recurrence-free  sur-
ival),  but  entails  long-term  surveillance  due  to  the  risk  of
ate  recurrence  and  latent  metastasis  [4,7].
onclusion
arotid  acinic  cell  carcinoma  is  a  rare  histologic  form;
hen  discovered,  however,  clinical  and  imaging  exploration
or  a  synchronous  contralateral  site  should  be  undertaken.
rolonged  surveillance  is  mandatory,  to  watch  out  for  recur-
ence  or  metachronous  onset.
The  existence  of  familial  forms  may  justify  screening  of
rst-degree  family  members.
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